HOME | CONTACT US | LOGIN | REGISTER
 
INVESTOR RELATIONS
Investor Home
Stock Quote/Chart
Stock Price Lookup
Calculator
News Releases
SEC Filings
Information Request
Email Alerts
 
  Investor Tool Kit
  HTML file Annual Report & Proxy
  PDF Investor Presentation
  PDF Corporate Fact Sheet
 
 
NASDAQ: GNBT 1.05
9 May 2008 1:31 PM ET
 
Print Print   Email Email page
 
 
Press Releases
 
Generex Study Proposes Increased Reporting of Clinical Outcomes to Support Reimbursement of Non-Injectable Insulin Options
  7 May 2008
   
Generex Biotechnology Announces North American Initiation of Generex Oral-lyn Phase III Diabetes Study
  7 Apr 2008
   
Generex Biotechnology and SciGen, Ltd. Enter Into Distribution Agreement for Generex Oral-lyn in China
  1 Apr 2008
   
Generex Biotechnology Raises $20,650,000 Through Private Placement
  1 Apr 2008
   
Generex Biotechnology Receives Indian Purchase Order for Generex Oral-lyn
  25 Mar 2008
   
Generex Biotechnology Clarifies Stance of Medical Affairs VP
  20 Mar 2008
   
Generex Biotechnology Announces That Its Protocol for Metcontrol, the Company's Proprietary Metformin Chewing Gum Product, Will Be Submitted to Regulatory Agencies for the Conduct of a Clinical Study
  12 Mar 2008
   
Generex Biotechnology Announces That Supplies for a Phase III Study of Generex Oral-lyn for a Number of Clinical Sites Have Been Packaged and are Ready for Shipping
  11 Mar 2008
   
Generex Biotechnology Comments On Recent Trading Activity
  10 Mar 2008
   
Generex Biotechnology to Make Presentations At International Conference On Hypertension, Lipids, Diabetes & Stroke Prevention
  6 Mar 2008
   
Generex Biotechnology Awarded Patents
  4 Mar 2008
   
Generex Biotechnology Extends Clinical Trial Agreement for Testing its Synthetic Avian Influenza Vaccine
  3 Mar 2008
   
Generex Biotechnology Receives Another Regulatory Approval to Conduct Phase III Clinical Trial for Generex Oral-lyn for One of the Largest Global Locations Selected by the Company
  14 Feb 2008
   
Generex Biotechnology Announces That An Investigators' Meeting Was Recently Held for Its Global Phase III Clinical Trial of Generex Oral-lyn
  4 Feb 2008
   
Generex Biotechnology Awarded New European Patent
  29 Jan 2008
   
Generex Biotechnology Receives Regulatory Approval to Initiate Phase III Clinical Trial for Generex Oral-lyn in First of the Global Locations Selected by the Company
  23 Jan 2008
   
Generex Biotechnology Announces Co-Authorship of Publications With Johns Hopkins University and Stallergenes S.A.
  22 Jan 2008
   
Generex Biotechnology Announces Generex Oral-lyn Marketing Launch Activities Made by the Company's Marketing and Distribution Licensee in India
  17 Jan 2008
   
Generex Biotechnology Announces Participation At 2008 Arab Health Congress Together With Middle Eastern Marketing and Distribution Partner
  15 Jan 2008
   
Generex Biotechnology Awarded Patent in Japan For Its Antigen Presentation Technology
  18 Dec 2007
   
Generex Biotechnology Receives $400,000 Purchase Order for OTC Products From Middle Eastern Marketing Partner
  13 Dec 2007
   
Generex Biotechnology Receives Approval From the Ministry of Health of the United Arab Emirates to Sell Generex Oral-Lyn to Prominent Diabetes Centre in the Middle East Region
  11 Dec 2007
   
Generex Biotechnology Makes Presentations At Latin-American Diabetes Congress and the Cuban Diabetes Conference
  16 Nov 2007
   
Noted Wall Street Analyst Highlights Generex Biotechnology in Report
  15 Nov 2007
   
Generex Biotechnology CEO Featured in Fox Business Channel Interview
  8 Nov 2007
   
Generex Biotechnology to Present At The Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City Today
  5 Nov 2007
   
First Prostate Cancer Patients Treated in a Phase I Clinical Trial as Part of a Collaboration Between Generex Biotechnology and the Saint Savas Cancer Hospital
  5 Nov 2007
   
Generex Biotechnology Receives Regulatory Approval to Sell Generex Oral-lyn in India
  1 Nov 2007
   
Generex Biotechnology to Host Conference Call for the Investment Community On Thursday, November 1st
  31 Oct 2007
   
Generex Biotechnology Makes Presentations At Annual Diabetes Scientific Symposia
  26 Oct 2007
   
Generex Biotechnology to Make Presentations at The Obesity Society Annual Scientific Meeting
  22 Oct 2007
   
Generex Biotechnology Announces Product Licensing and Distribution Agreement for Generex Oral-lyn in South Africa
  18 Oct 2007
   
CORRECTING and REPLACING -- Generex Biotechnology Appoints Leading Contract Research Organization to Manage Global Phase III Trials For Generex Oral-lyn
  16 Oct 2007
   
Generex Biotechnology Appoints Leading Contract Research Organization to Manage Global Phase III Trials For Generex Oral-lyn
  16 Oct 2007
   
Generex Biotechnology Provides Middle Eastern Master Licensee Update On Generex Oral-lyn Regulatory Filings
  15 Oct 2007
   
Generex Biotechnology RNAi-Based Tumor Vaccine Set for Trials in China to be Presented At Leading International Oncology Meeting
  9 Oct 2007
   
Generex Biotechnology Awarded United States Patent
  2 Oct 2007
   
Generex Biotechnology Announces Distribution Arrangement for Glucose RapidSpray in South Africa
  25 Sep 2007
   
Generex Biotechnology to Make Podium Presentation At 43rd Annual Meeting of the European Association for the Study of Diabetes
  18 Sep 2007
   
Generex Biotechnology to Collaborate With Leading Investigator At the Univerity of Rochester On Pandemic Avian Influenza Vaccine
  22 Aug 2007
   
Showing 1-40 of 221 Page: 1 2 3 ... 6  Next 40
 
 
Privacy Policy